IDEMIA Will Present Its Full Year-2019 Financial Results to Investors on February 19, 2020
IDEMIA, the world leader in Augmented Identity, today announced that it will present its full year-2019 financial results to investors on Wednesday February 19, 2020.
Yann Delabrière (President & CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 4:30 pm CET (3:30 pm London Time / 10:30 am New York Time).
For more information, please refer to our website: https://investors.idemia.com/
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With 13,000 employees around the world, IDEMIA serves clients in 180 countries.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NOVAREMED-AG25.5.2020 18:32:11 CEST | Press release
Novaremed Announces IND Submitted to U.S. FDA for Phase 2 Study of NRD135S.E1 for the Treatment of Painful Diabetic Peripheral Neuropathy; Also Announces the Appointment of Three New Board Members
EURID25.5.2020 13:32:05 CEST | Press release
Closer Collaboration between the EUIPO and EURid to Benefit SMEs
TIP-TRAILER-SERVICES25.5.2020 10:07:11 CEST | Press release
TIP Trailer Services Announces Appointment of New CFO
TEVA-PHARMACEUTICAL25.5.2020 08:02:15 CEST | Press release
Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine
JEOL25.5.2020 08:02:15 CEST | Press release
JEOL: Release of a New Schottky Field Emission Scanning Electron Microscope JSM-IT800
IPSEN23.5.2020 07:02:12 CEST | Press release
Ipsen: New Surveys Show Over 80% of Patients with Spasticity and Cervical Dystonia Treated with Botulinum Toxin-A Experience Debilitating Symptom Recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom